Events - Event View
This is the "Event Detail" view, showing all available information for this event.
If registration is required or recommended, click the 'Register Now' button to start the process.
If the event has passed, click the "Event Report" button to read a report and view photos that were uploaded.
The Evidence for High Intensity Interval Training for Patients with CAD
PRESENTER: John C. Quindry, PhD, FACSM, FCVS-APS; University of Montana
BRIEF SUMMARY
Exercise-based cardiac rehabilitation is integral to secondary prevention in patients with coronary artery disease (CAD). Recently, the effectiveness and “superiority” of high-intensity interval training (HIIT) is a purported time-saving alternative to “traditional” moderate-intensity continuous training (MICT) in cardiac rehabilitation. The rationale for HIIT adoption is, however, not fully substantiated in the scientific literature. Established guidelines for exercise testing and training, when carefully adhered to, reduce the likelihood of triggering a cardiac event or inducing musculoskeletal injury. Clinicians should likewise consider patient risk stratification and introduce HIIT as an alternative to MICT only after patients exhibit stable and asymptomatic responses to vigorous exercise training. Although HIIT adherence appears comparable with MICT during outpatient rehabilitation, compliance drops dramatically for unsupervised exercise. Despite the enthusiasm surrounding HIIT, its main advantage over MICT appears to be short-term exercise performance outcomes and indices of vascular function. Regarding benefits to cardiovascular disease risk factor modification, management of vital signs, and measures of cardiac performance, current evidence indicates that HIIT does not outperform MICT. Long-term outcomes to HIIT are currently uncertain and logistical constraints to HIIT incorporation need additional clarification. Based on these limited findings, derived from facilities and clinicians at the forefront of cardiac rehabilitation, the routine adoption of HIIT should be viewed cautiously. During this presentation we will review specific research directives that are needed before the safety and effectiveness of HIIT can be confirmed and widely adopted in patients with known or suspected CAD, especially in unsupervised, nonmedical settings.
Cost
CEPA professional/associate members: $15
CEPA student members: $10
Non-members: $50 --
Join today and receive free registration for this webinar. A coupon code is included in your membership confirmation email.
Join today!
CECs: 1 (one) CEC
RECORDING: This event will be recorded. Access to a recording of this event will be available to all who register for 3 months after the event.
LEARNING OBJECTIVES
- To understand what evidence does and does not exist regarding the efficacy of HIIT training for persons with CAD.
- To understand what evidence exists for HIIT exercise training in low/moderate/high risk patients based on AACVPR criteria.
- To understanding the outcomes of HIIT training relative to exercise capacity, disease risk factor modification, cardiac performance, disease recurrence/prevention, and for incidence of depression and anxiety.
- To understand how HIIT training efficacy in cardiac populations relative to the number of observable hours needed to confirm/refute whether this type of exercise precipitates untoward cardiac events.
- To understand what evidence exists for HIIT versus MICT within the context of quasi-experimental clinical trials as compared to full experimental clinical trials.
ABOUT THE PRESENTER
Dr Quindry, “JQ” completed degrees in exercise science and exercise physiology before completing a PhD in biomedical sciences from the Quillen College of Medicine at East Tennessee State University. JQ has significant experience working in cardiopulmonary and cardio-oncology rehabilitation settings. As a professor of pre-health and allied health students, he is committed to training a diverse group of professionals that are notably competent in the workplace.